Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial (Q43696394)
Jump to navigation
Jump to search
scientific article published on 15 May 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial |
scientific article published on 15 May 2012 |
Statements
1 reference
Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial (English)
1 reference
Paul P Tak
1 reference
Andra Balanescu
1 reference
Vira Tseluyko
1 reference
Silvia Bojin
1 reference
Edit Drescher
1 reference
Dan Dairaghi
1 reference
Shichang Miao
1 reference
Vittorio Marchesin
1 reference
Juan Jaen
1 reference
Thomas J Schall
1 reference
Pirow Bekker
1 reference
15 May 2012
1 reference
1 reference
Identifiers
1 reference